A reforma de saúde indiana oferece oportunidades prósperas no mercado farmacêutico:
August 25, 2020
A Global Farma Insights falou com Deepak Sapra (abaixo), CEO de Ingredientes Ativos e Serviços Farmacêuticos nos Laboratórios do Dr. Reddy para sua perspectiva no estado atual do setor de saúde e farmacêutico indiano e como está providenciando oportunidades para fabricantes de medicações domésticos e multinacionais apesar dos desafios oferecidos pela atual pandemia de coronavírus.
Para ler a entrevista clique aqui
+91 4049002253 Aviso legal
No information on this website, including any reference to any product or service constitutes an offer for sale or be construed as representing an offer for sale. Products protected under valid patents are not offered or supplied for commercial use. However, in certain cases, at Dr. Reddy's sole discretion, and subject to local legal requirement, the research quantities of such products may be offered for the purpose of regulatory submissions under Section 107A of the Indian Patent Act (Bolar exemption), wherever such regulatory exemptions exist. The buyers should make their independent evaluation of the product or service including, patent scenario in their respective markets and will be responsible for all patent related liabilities Dr. Reddy's disclaims all warranties, express or implied, including but not limited to warranties of merchantability, fitness for a particular purpose and non-infringement.